封面
市场调查报告书
商品编码
1953907

非侵入性人工呼吸器市场 - 全球产业规模、份额、趋势、机会及预测(按产品、应用、最终用户、地区和竞争格局划分),2021-2031年

Non-Invasive Ventilators Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End User, By Region & Competition, 2021-2031F

出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球非侵入性通气市场预计将从 2025 年的 32.7 亿美元成长到 2031 年的 45.1 亿美元,复合年增长率为 5.51%。

这些专用医疗设备可透过鼻罩或面罩进行通气,并提供正压通气,有效避免了侵入性气管插管。市场成长趋势主要受慢性呼吸系统疾病(如慢性阻塞性肺病(COPD))在全球日益普遍以及老龄化人口不断增加导致呼吸衰竭的驱动。此外,旨在降低医院再入院率和营运成本的居家照护模式策略转型也显着增加了对这些非侵入性治疗方案的需求。

市场概览
预测期 2027-2031
市场规模:2025年 32.7亿美元
市场规模:2031年 45.1亿美元
复合年增长率:2026-2031年 5.51%
成长最快的细分市场 医院和诊所
最大的市场 北美洲

儘管存在这些成长要素,但由于操作这些精密设备所需的熟练医护人员严重短缺,市场仍面临巨大的阻力。美国呼吸照护协会的数据显示,到2024年,87%的呼吸照护主管将意识到呼吸治疗师的短缺问题。这种人才短缺严重限制了患者获得关键的非侵入性通气治疗的机会,并阻碍了市场在急诊和居家医疗领域的更广泛扩张。

市场驱动因素

空气品质恶化加剧了慢性呼吸系统疾病的快速成长,这是推动非侵入性通气系统普及应用的主要因素。随着都市化的不断推进,长期暴露于粒状物会加速慢性阻塞性肺病(COPD)的发展,导致患者需要持续可靠的呼吸支持。这种环境影响显着扩大了需要治疗性介入的患者群体。根据美国肺臟协会于2024年4月发布的《2024年空气污染状况》报告,美国约有1.312亿人居住在臭氧或颗粒物污染程度超标的地区。这项数据与呼吸系统疾病盛行率的上升直接相关,促使医疗保健机构优先考虑采用非侵入性治疗方法以实现有效管理。

同时,面向居家照护的技术创新正在改变竞争格局。製造商正在开发支援远端患者监护的紧凑型云端设备,从而减少患者频繁就医的需求。强劲的财务业绩支撑了这一转变。 Fisher & Paykel Healthcare 于 2024 年 5 月发布的 2024 年年度报告显示,其居家医疗产品系列的营业收入增长了 18%,显示医院以外的人工呼吸器解决方案需求旺盛。这些创新正在推动整体市场收入的成长。 ResMed 于 2024 年 8 月发布的 2024 年第四季业绩报告显示,季度营收成长 9% 至 12.2 亿美元,凸显了该产业的蓬勃发展。

市场挑战

熟练医护人员的严重短缺是全球无创通气市场成长的一大障碍。儘管对这类设备的需求不断增长,但无创正压通气的成功实施很大程度上依赖于呼吸治疗师的临床技能,以应对诸如面罩漏气、压力调节和患者同步等问题。缺乏训练有素的人员会导致治疗效果降低和失败率升高,迫使医疗机构削减对新设备的投资。因此,硬体市场面临的限制因素并非源自于病患需求不足,而是源自于能够安全有效地操作该技术的专业人员短缺。

由于缺乏能够在医院外监测患者的临床医生,人才短缺尤其阻碍了居家医疗的策略转型。不断增长的患者群体与现有医护人员之间的差距持续扩大,限制了这些治疗方法的扩充性。根据美国国家呼吸治疗委员会统计,到2024年,仅有13065名新认证的医护人员,远低于填补退休人员空缺和应对日益严重的呼吸系统疾病负担所需的招聘人数。

市场趋势

人工智慧 (AI) 整合到自适应压力传输领域正在变革这一领域,它使设备能够根据患者的呼吸模式即时自主调节气流。这些先进的演算法增强了患者与人工呼吸器的同步性,改善了复杂呼吸系统疾病的治疗效果,有效地将技术从简单的监测发展到主动、自动化的治疗优化。这种发展减轻了临床医生的手动负担,同时确保了与当前生理需求相符的精准呼吸支持。这些智慧解决方案的广泛应用显着提升了製造商的财务表现。例如,瑞思迈 (ResMed) 截至 2025 年 8 月的 10-K 年度报告显示,其睡眠和呼吸健康业务部门的收入净额增长了 10%,达到 45 亿美元,这主要得益于其数位健康和​​自适应治疗平台在全球范围内的广泛应用。

同时,市场在新生儿专用非侵入性介面方面取得了显着进展,这些介面旨在降低早产儿侵入性插管的风险。符合人体工学的鼻罩和专用导管等创新产品在最大限度减少皮肤破损和预防肺支气管发育不良等长期併发症发挥着关键作用,从而促进了新生儿加护病房更早地采用非侵入性支持。使用专用设备保护这些脆弱的儿童患者,推动了对先进重症监护解决方案的强劲需求。反映此一趋势的是,德尔格公司于2025年3月发布的2024年度报告显示,其税前净利(EBIT)成长16.6%,达到1.94亿欧元。该公司将这项财务表现归功于对其全面的医疗技术产品组合,特别是其尖端新生儿通气技术的持续需求。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章:客户评价

第五章 全球非侵入性人工呼吸器市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依产品分类(非侵入性正压通气{PPV},非侵入性负压通气{NPV})
    • 依应用领域(慢性阻塞性肺病和气喘、呼吸窘迫症候群等)
    • 按最终使用者(医院/诊所、门诊护理中心、其他)
    • 按地区
    • 按公司(2025 年)
  • 市场地图

6. 北美非侵入性人工呼吸器市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲:国家分析
    • 我们
    • 加拿大
    • 墨西哥

7. 欧洲非侵入性人工呼吸器市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲:国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

8. 亚太地区非侵入性人工呼吸器市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区:国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

9. 中东和非洲非侵入性人工呼吸器市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲:国家分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

10. 南美洲非侵入性人工呼吸器市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲:国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 司机
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章 全球非侵入性人工呼吸器市场:SWOT分析

第十四章:波特五力分析

  • 产业竞争
  • 新进入者的可能性
  • 供应商电力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • ResMed Inc.
  • Teleflex Incorporated
  • Hamilton Bonaduz AG
  • Heyer medical AG
  • Koninklijke Philips NV
  • Airon Corporation
  • Fisher & Paykel Healthcare Limited
  • Mindray Medical International Limited
  • Phoenix Medical Systems Pvt. Ltd.
  • Smiths Group plc

第十六章 策略建议

第十七章:关于研究公司及免责声明

简介目录
Product Code: 23907

The Global Non-Invasive Ventilators Market is projected to expand from a valuation of USD 3.27 Billion in 2025 to USD 4.51 Billion by 2031, reflecting a Compound Annual Growth Rate of 5.51%. These specialized medical devices facilitate ventilation through nasal interfaces or masks, delivering positive airway pressure and effectively bypassing the need for invasive endotracheal intubation. The market's upward trajectory is largely fueled by the increasing global prevalence of chronic respiratory ailments, such as Chronic Obstructive Pulmonary Disease, alongside an aging demographic that is more prone to respiratory failure. Additionally, the strategic pivot toward home-based care models, intended to reduce hospital readmission rates and lower operational expenses, is creating significant demand for these non-invasive therapeutic solutions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.27 Billion
Market Size 2031USD 4.51 Billion
CAGR 2026-20315.51%
Fastest Growing SegmentHospitals & Clinics
Largest MarketNorth America

Despite these positive growth factors, the market encounters substantial headwinds due to a critical shortage of skilled healthcare practitioners necessary for managing these sophisticated devices. Data from the American Association for Respiratory Care indicates that in 2024, 87% of respiratory care executives identified a current deficit of respiratory therapists. This workforce scarcity severely restricts patient access to vital non-invasive ventilation therapies and hampers the broader scalability of the market across both acute and home care environments.

Market Driver

The surging prevalence of chronic respiratory conditions, exacerbated by deteriorating air quality, acts as a primary engine for the adoption of non-invasive ventilation systems. As urbanization increases, prolonged exposure to particulate matter hastens the development of Chronic Obstructive Pulmonary Disease, necessitating consistent and reliable respiratory support. This environmental impact significantly widens the patient demographic requiring therapeutic intervention. According to the American Lung Association's 'State of the Air 2024' report published in April 2024, approximately 131.2 million people in the United States reside in areas plagued by unhealthy ozone or particle pollution levels, a statistic that directly correlates with rising respiratory morbidity and drives healthcare providers to prioritize non-invasive modalities for efficient management.

Simultaneously, technological advancements targeted at home-based care are transforming the competitive landscape. Manufacturers are engineering compact, cloud-enabled devices that support remote patient monitoring, thereby decreasing the necessity for frequent hospital visits. This transition is substantiated by robust financial results; Fisher & Paykel Healthcare's 'Annual Report 2024' from May 2024 notes an 18% increase in operating revenue for their Homecare product group, signaling a strong appetite for out-of-hospital ventilation solutions. Such innovations are bolstering overall market revenue, as evidenced by ResMed's 'Fourth Quarter Fiscal Year 2024 Results' in August 2024, which reported a 9% growth in quarterly revenue to $1.22 billion, highlighting the sector's vigorous expansion.

Market Challenge

The critical shortage of skilled healthcare professionals presents a formidable obstacle to the growth of the Global Non-Invasive Ventilators Market. Although demand for these devices is increasing, the successful implementation of non-invasive positive pressure ventilation depends heavily on the clinical proficiency of respiratory therapists to manage issues such as mask leaks, pressure titration, and patient synchrony. A deficiency in trained personnel leads to suboptimal therapy delivery and higher failure rates, compelling healthcare providers to restrict their investments in new equipment. Consequently, the hardware market faces constraints not due to a lack of patient demand, but rather the unavailability of a specialized workforce capable of operating the technology safely and effectively.

This workforce shortage specifically compromises the strategic transition toward home-based care, as there are insufficient clinicians available to monitor patients outside of hospital settings. The disparity between the expanding patient population and the available workforce continues to widen, limiting the potential scalability of these therapies. According to the National Board for Respiratory Care, only 13,065 new credentials were awarded to practitioners in 2024, a number that fails to meet the recruitment levels required to replace retiring staff and address the escalating prevalence of respiratory pathologies.

Market Trends

The integration of Artificial Intelligence for Adaptive Pressure Delivery is transforming the sector by empowering devices to autonomously modulate airflow in response to real-time patient breathing patterns. These sophisticated algorithms enhance patient-ventilator synchrony and augment treatment efficacy for complex respiratory conditions, effectively elevating the technology from simple monitoring to active, automated therapy optimization. This evolution alleviates the manual workload on clinicians while ensuring precise respiratory support aligned with immediate physiological requirements. The growing uptake of these intelligent solutions is significantly enhancing manufacturer performance; for instance, ResMed's 'Form 10-K Annual Report' from August 2025 indicates that net revenue for the Sleep and Breathing Health business rose by 10% to $4.5 billion, driven by the global adoption of their digital health and adaptive therapeutic platforms.

In parallel, the market is experiencing notable advancements in neonatal-specific non-invasive interfaces designed to reduce the risks linked to invasive intubation in premature infants. Innovations such as ergonomic nasal masks and specialized prongs play a crucial role in minimizing skin trauma and preventing long-term complications like bronchopulmonary dysplasia, thereby promoting the early utilization of non-invasive support in neonatal intensive care units. This emphasis on safeguarding vulnerable pediatric patients through specialized hardware is fueling strong demand for high-end critical care solutions. Reflecting this trend, Drager's 'Annual Report 2024' from March 2025 reported a 16.6% rise in Earnings Before Interest and Taxes (EBIT) to EUR 194.0 million, a financial achievement attributed to sustained demand for their comprehensive medical technology portfolio, including leading neonatal ventilation technologies.

Key Market Players

  • ResMed Inc.
  • Teleflex Incorporated
  • Hamilton Bonaduz AG
  • Heyer medical AG
  • Koninklijke Philips N.V.
  • Airon Corporation
  • Fisher & Paykel Healthcare Limited
  • Mindray Medical International Limited
  • Phoenix Medical Systems Pvt. Ltd.
  • Smiths Group plc

Report Scope

In this report, the Global Non-Invasive Ventilators Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Non-Invasive Ventilators Market, By Product

  • Non-invasive Positive Pressure Ventilators {PPV}
  • Non-invasive Negative Pressure Ventilators {NPV}

Non-Invasive Ventilators Market, By Application

  • COPD and Asthma
  • Respiratory Distress Syndrome
  • Others

Non-Invasive Ventilators Market, By End User

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Non-Invasive Ventilators Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Non-Invasive Ventilators Market.

Available Customizations:

Global Non-Invasive Ventilators Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Non-Invasive Ventilators Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Non-invasive Positive Pressure Ventilators {PPV}, Non-invasive Negative Pressure Ventilators {NPV})
    • 5.2.2. By Application (COPD and Asthma, Respiratory Distress Syndrome, Others)
    • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Non-Invasive Ventilators Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Non-Invasive Ventilators Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Non-Invasive Ventilators Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Non-Invasive Ventilators Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Non-Invasive Ventilators Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Non-Invasive Ventilators Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Non-Invasive Ventilators Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Non-Invasive Ventilators Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Non-Invasive Ventilators Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Non-Invasive Ventilators Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Non-Invasive Ventilators Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Non-Invasive Ventilators Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Non-Invasive Ventilators Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Non-Invasive Ventilators Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Non-Invasive Ventilators Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Non-Invasive Ventilators Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Non-Invasive Ventilators Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Non-Invasive Ventilators Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Non-Invasive Ventilators Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Non-Invasive Ventilators Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Non-Invasive Ventilators Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Non-Invasive Ventilators Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Non-Invasive Ventilators Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Non-Invasive Ventilators Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Non-Invasive Ventilators Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. ResMed Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Teleflex Incorporated
  • 15.3. Hamilton Bonaduz AG
  • 15.4. Heyer medical AG
  • 15.5. Koninklijke Philips N.V.
  • 15.6. Airon Corporation
  • 15.7. Fisher & Paykel Healthcare Limited
  • 15.8. Mindray Medical International Limited
  • 15.9. Phoenix Medical Systems Pvt. Ltd.
  • 15.10. Smiths Group plc

16. Strategic Recommendations

17. About Us & Disclaimer